NCT04896645View on ClinicalTrials.gov

Albuterol Integrated Adherence Monitoring in Children With Asthma

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

June 22, 2022

Study Completion Date

June 22, 2022

Conditions
Asthma in Children
Interventions
DEVICE

Digihaler Albuterol Device by TEVA

Patient with asthma will have their regular albuterol rescue inhaler replaced with Digihaler, they will also be asked to perform gamified spirometry (Aluna) at home

Trial Locations (1)

90027

Children's Hospital Los Angeles, Los Angeles

All Listed Sponsors
collaborator

Teva Pharmaceuticals USA

INDUSTRY

lead

Children's Hospital Los Angeles

OTHER